Clinical comparability and European biosimilar regulations
Nat Biotechnol
.
2010 Jan;28(1):28-31.
doi: 10.1038/nbt0110-28.
Authors
Huub Schellekens
1
,
Ellen Moors
Affiliation
1
Huub Schellekens is in the Departments of Pharmaceutical Sciences and Innovation Studies, Utrecht University, Utrecht, The Netherlands. h.schellekens@uu.nl
PMID:
20062035
DOI:
10.1038/nbt0110-28
No abstract available
MeSH terms
Biopharmaceutics / legislation & jurisprudence*
Drug Evaluation, Preclinical
Drug Recalls
Europe
European Union
Humans
Legislation, Drug*